RACK1 and hepatocellular carcinoma: It has been reported that O-GlcNAcylation of RACK1 at the amino acid serine122 could promote its stability, thus driving the tumorigenesis of hepatocellular carcinoma [22, 41] and cervical cancer [11, 42] progression.